Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

MYL

Mylan NV (MYL)

Mylan NV
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:MYL
일자시간출처헤드라인심볼기업
2022/05/0705:43Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:MYLMylan NV
2021/09/2919:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:MYLMylan NV
2021/09/2822:28Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:MYLMylan NV
2021/09/1106:02Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:MYLMylan NV
2020/11/2807:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 13 and 15(d) (15-15d)NASDAQ:MYLMylan NV
2020/11/2007:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MYLMylan NV
2020/11/1706:03Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:MYLMylan NV
2020/11/0623:05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MYLMylan NV
2020/11/0622:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MYLMylan NV
2020/11/0620:59PR Newswire (US)Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc.NASDAQ:MYLMylan NV
2020/11/0221:30PR Newswire (US)Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets for ViatrisNASDAQ:MYLMylan NV
2020/10/3103:23Dow Jones NewsPfizer, Mylan Agreement With FTC Over Upjohn Deal, Clearing Way for November ClosingNASDAQ:MYLMylan NV
2020/10/3102:39PR Newswire (US)Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and UpjohnNASDAQ:MYLMylan NV
2020/10/3102:22Business WireMylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and UpjohnNASDAQ:MYLMylan NV
2020/09/1520:15PR Newswire (US)Mylan and Development Partner, Synthon, Win Significant European Patent Office Ruling Related to Copaxone® 40mg/mLNASDAQ:MYLMylan NV
2020/09/1520:00PR Newswire (US)Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and UpjohnNASDAQ:MYLMylan NV
2020/09/1206:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MYLMylan NV
2020/09/1002:07PR Newswire (US)Mylan to Present at the Morgan Stanley Virtual 18th Annual Global Healthcare ConferenceNASDAQ:MYLMylan NV
2020/09/1002:05PR Newswire (US)Mylan to Present at the BofA Securities Virtual Global Healthcare ConferenceNASDAQ:MYLMylan NV
2020/09/0815:00PR Newswire (US)Mylan to Acquire Aspen's Thrombosis Business in EuropeNASDAQ:MYLMylan NV
2020/08/3119:06Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:MYLMylan NV
2020/08/3119:00PR Newswire (US)Mylan and Biocon Biologics Announce Launch of Semglee™ (insulin glargine injection) in the U.S. to Expand Access for Patien...NASDAQ:MYLMylan NV
2020/08/2907:30PR Newswire (US)Mylan Initiates Voluntary Nationwide Recall of Four Lots of Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP ...NASDAQ:MYLMylan NV
2020/08/1921:09Dow Jones NewsMylan Launches First U.S. Generic of Biogen MS Drug TecfideraNASDAQ:MYLMylan NV
2020/08/1920:00PR Newswire (US)Mylan Brings Critical Access to the Multiple Sclerosis Community by Launching a More Affordable Treatment Option Through a Fi...NASDAQ:MYLMylan NV
2020/08/1307:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MYLMylan NV
2020/08/1222:00PR Newswire (US)Mylan and Sesame Workshop Partner to Provide Socio-Emotional Support Resources to Families Impacted by COVID-19NASDAQ:MYLMylan NV
2020/08/0706:28Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MYLMylan NV
2020/08/0621:45Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MYLMylan NV
2020/08/0619:30PR Newswire (US)Mylan Reports Strong Second Quarter and First Half 2020 Results and Updates 2020 GuidanceNASDAQ:MYLMylan NV
 검색 관련기사 보기:NASDAQ:MYL